Xinhui Du

516 total citations
34 papers, 276 citations indexed

About

Xinhui Du is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Xinhui Du has authored 34 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 11 papers in Molecular Biology and 10 papers in Surgery. Recurrent topics in Xinhui Du's work include Sarcoma Diagnosis and Treatment (18 papers), Bone Tumor Diagnosis and Treatments (7 papers) and Cancer-related molecular mechanisms research (7 papers). Xinhui Du is often cited by papers focused on Sarcoma Diagnosis and Treatment (18 papers), Bone Tumor Diagnosis and Treatments (7 papers) and Cancer-related molecular mechanisms research (7 papers). Xinhui Du collaborates with scholars based in China and United States. Xinhui Du's co-authors include Gang Li, Keyu Liu, Jiaqiang Wang, Weitao Yao, Zhichao Tian, Qiqing Cai, Wei Hua, Chao Li, Jinpo Yang and Peng Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Frontiers in Psychology and Medicine.

In The Last Decade

Xinhui Du

29 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinhui Du China 10 125 115 105 79 33 34 276
He Yue China 7 109 0.9× 59 0.5× 102 1.0× 51 0.6× 42 1.3× 26 265
Wenhua Yuan China 9 147 1.2× 102 0.9× 82 0.8× 48 0.6× 35 1.1× 20 315
Olena Preobrazhenska Canada 7 176 1.4× 60 0.5× 125 1.2× 86 1.1× 21 0.6× 7 339
Ruifeng Xue China 9 99 0.8× 59 0.5× 93 0.9× 76 1.0× 20 0.6× 24 258
Shuheng Bai China 10 163 1.3× 131 1.1× 44 0.4× 38 0.5× 47 1.4× 23 279
Huayong Zhang China 12 238 1.9× 110 1.0× 49 0.5× 49 0.6× 35 1.1× 17 339
Hongya Xie China 8 175 1.4× 149 1.3× 91 0.9× 47 0.6× 46 1.4× 19 329
Rongfeng Song China 9 110 0.9× 71 0.6× 59 0.6× 49 0.6× 22 0.7× 16 225
Xiaoyong Hu China 12 140 1.1× 68 0.6× 50 0.5× 36 0.5× 100 3.0× 25 356
Yunhua Mao China 10 249 2.0× 151 1.3× 97 0.9× 57 0.7× 32 1.0× 20 362

Countries citing papers authored by Xinhui Du

Since Specialization
Citations

This map shows the geographic impact of Xinhui Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinhui Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinhui Du more than expected).

Fields of papers citing papers by Xinhui Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinhui Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinhui Du. The network helps show where Xinhui Du may publish in the future.

Co-authorship network of co-authors of Xinhui Du

This figure shows the co-authorship network connecting the top 25 collaborators of Xinhui Du. A scholar is included among the top collaborators of Xinhui Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinhui Du. Xinhui Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yao, Weitao, Yichao Fan, Xinhui Du, et al.. (2025). Radiomics for predicting sensitivity to neoadjuvant chemotherapy in osteosarcoma: current status and advances. Oncology Reviews. 19. 1633211–1633211.
2.
Su, Qiang, et al.. (2025). The role and research progress of the MET signalling pathway in targeted therapy for osteosarcoma. Oncology Reviews. 19. 1615111–1615111. 1 indexed citations
3.
Du, Xinhui, et al.. (2024). Clinical application of platelet rich plasma to promote healing of open hand injury with skin defect. Regenerative Therapy. 26. 308–314. 3 indexed citations
4.
Du, Xinhui, et al.. (2024). A New Method of Krackow Suture Combined with Nice Knot for the Treatment of Inferior Patellar Fractures. Indian Journal of Orthopaedics. 58(3). 242–249.
5.
Zhang, Peng, et al.. (2024). The application of custom 3D-printed prostheses with ultra-short stems in the reconstruction of bone defects: a single center analysis. Frontiers in Bioengineering and Biotechnology. 12. 1349819–1349819. 2 indexed citations
6.
7.
Yuan, Junhui, et al.. (2024). Alveolar Soft Tissue Sarcoma: Correlation of MRI Features With Histological Grading and Patient Prognosis. Journal of Magnetic Resonance Imaging. 61(3). 1482–1491.
8.
Yan, Qiang, et al.. (2023). [Efficacy and safety of Anlotinib in the treatment of advanced sarcoma].. PubMed. 45(10). 904–910. 2 indexed citations
9.
Liu, Xin, et al.. (2023). Reducing anxiety and improving self-acceptance in children and adolescents with osteosarcoma through group drawing art therapy. Frontiers in Psychology. 14. 1166419–1166419. 2 indexed citations
10.
11.
Yao, Weitao & Xinhui Du. (2023). Study of microwave ablation in patients with unresectable soft tissue sarcoma.. Journal of Clinical Oncology. 41(16_suppl). e23545–e23545. 1 indexed citations
12.
Zhang, Boya, et al.. (2023). DLX2 promotes osteosarcoma epithelial-mesenchymal transition and doxorubicin resistance by enhancing HOXC8-CDH2 axis. iScience. 26(11). 108272–108272. 3 indexed citations
13.
Hua, Wei, et al.. (2023). Propofol Regulates ER Stress to Inhibit Tumour Growth and Sensitize Osteosarcoma to Doxorubicin. International Journal of Clinical Practice. 2023. 1–8. 3 indexed citations
14.
Wang, Jiaqiang, Fan Zhang, Shuping Dong, et al.. (2023). Apatinib plus chemotherapy for non-metastatic osteosarcoma: a retrospective cohort study. Frontiers in Oncology. 13. 1227461–1227461.
15.
Du, Xinhui, et al.. (2023). Molecular mechanisms of osteosarcoma metastasis and possible treatment opportunities. Frontiers in Oncology. 13. 1117867–1117867. 15 indexed citations
16.
Yao, Weitao, Xinhui Du, Jiaqiang Wang, et al.. (2022). Long-Term Efficacy and Safety of Anlotinib as a Monotherapy and Combined Therapy for Advanced Sarcoma. OncoTargets and Therapy. Volume 15. 669–679. 9 indexed citations
17.
Du, Xinhui, et al.. (2020). Gene expression regulations by long noncoding RNAs and their roles in cancer. Pathology - Research and Practice. 216(6). 152983–152983. 17 indexed citations
18.
Du, Xinhui, Wei Hua, Po Li, & Weitao Yao. (2020). Artificial Intelligence (AI) Assisted CT/MRI Image Fusion Technique in Preoperative Evaluation of a Pelvic Bone Osteosarcoma. Frontiers in Oncology. 10. 1209–1209. 11 indexed citations
19.
Tian, Zhichao, Huimin Liu, Fan Zhang, et al.. (2020). Retrospective review of the activity and safety of apatinib and anlotinib in patients with advanced osteosarcoma and soft tissue sarcoma. Investigational New Drugs. 38(5). 1559–1569. 36 indexed citations
20.
Tian, Zhichao, Yonghao Yang, Jinpo Yang, et al.. (2020). <p>Safety and Efficacy of PD-1 Inhibitors Plus Chemotherapy in Advanced Soft Tissue Sarcomas: A Retrospective Study</p>. Cancer Management and Research. Volume 12. 1339–1346. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by He Yue Breakdown of academic impact, for papers by Wenhua Yuan Breakdown of academic impact, for papers by Olena Preobrazhenska Breakdown of academic impact, for papers by Ruifeng Xue Breakdown of academic impact, for papers by Shuheng Bai Breakdown of academic impact, for papers by Huayong Zhang Breakdown of academic impact, for papers by Hongya Xie Breakdown of academic impact, for papers by Rongfeng Song Breakdown of academic impact, for papers by Xiaoyong Hu Breakdown of academic impact, for papers by Yunhua Mao
Rankless by CCL
2026